Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.

TROPHIC TWITTER FEED

Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

Although we continue to #WFH, we can still celebrate some good news this month at Trophic. Today we would like to welcome our newest #TeamBean member, @SophiaHergenhan, as well as congratulate @jacobvinfo on his promotion to Account Manager. #Congrats #BiotechStrong #TrophicTeam

Working from home, like Bean, our VP #StressManagement & Nutrition? Bean's sharing a @HarvardBiz video with tips on how to #WFH, including advice on how to work alongside pets: https://t.co/KA39DwbnEG. If you have extra advice on how to make #HomeOffice a success, let us know!

Congratulations to @OncoOne on their EUR 13M #SeriesA and company launch. We look forward to following the Company's future developments in the #Oncology space.

Labiotech.eu@Labiotech_eu

Austrian startup @OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid #tumor cancers. #biotech #Austria
https://t.co/yffvFhH5tg

Load More...